WATTLE HEALTH AUSTRALIA COMPLETES CAPITAL RAISING FOR CBDG JOINT VENTURE
• Wattle Health Australia Limited (WHA) has completed the Entitlement Offer raising approximately $33.9 million.
• WHA is now fully funded to meet its funding obligations as part of the CBDG Joint Venture.
• Transformational CBDG Joint Venture will see WHA become one of only a few vertically integrated nutritional dairy companies.
14 June 2018: Wattle Health Australia Limited (ASX: WHA) is pleased to announce the completion of its 1 for 5 pro rata non-renounceable entitlement offer (Entitlement Offer), announced on 21 May 2018. The Entitlement Offer closed on Friday, 8 June 2018, which raised a total of approximately $16.0 million. Eligible shareholders subscribed for approximately 8.0 million new shares under the Entitlement Offer and approximately 4.8 million new shares under the top-up facility. Entitlements not taken up by eligible shareholders were offered to new and existing institutional and sophisticated investors (Shortfall Offer). The Shortfall Offer raised approximately $17.9 million bringing the total amount raised under the Entitlement Offer to $33.9 million. The Entitlement Offer raised a total of $33.9 million and together with the commitments from institutional investors to subscribe for approximately $20.0 million (Placement), results in a total equity capital raising of $53.9 million. Settlement of the Entitlement Offer and Placement are expected to occur on Thursday, 14 June 2018, with the new shares issued expected to commence trading on ASX on Monday, 18 June 2018. Funds raised from the Entitlement Offer and Placement, together with the loan facility secured with Prospere Advisor Limited (Prospere) as announced on 21 May 2018, fully funds WHA’s obligations under the CBDG Joint Venture. WHA through its participation in the CBDG Joint Venture will become a vertically integrated Australian organic nutritional dairy company, having influence (and investment) in the entire value chain from farm to consumer.
WHA Price at posting:
$1.40 Sentiment: Buy Disclosure: Held